Skip to main content
. 2019 Feb 26;9:6. doi: 10.1186/s13395-019-0190-5

Fig. 2.

Fig. 2

T cell proliferation in response to osteopontin. BrdU incorporation in spleen cells (isolated from mice that received allografts) treated with vehicle, Con A or recombinant mouse osteopontin. WT, wild-type; KO, osteopontin-null. Data are expressed as absorbance at 450 nm and presented as mean ± s.e.m.; n = 3 animals from each group. Two-way ANOVA with Tukey’s multiple comparison test was used to compare values with the value for vehicle-treated (Veh) cells of the same genotype; ****p < 0.0001